Serum CK18-M30 levels increased significantly in the PCa+LDH-A inhibitor+Docetaxel group when compared to the PCa (p < 0.0001), PCa+LDH-A inhibitor (p < 0.0001) (Figure 2 C). The gene discussed is KRT18; the disease is posterior cortical atrophy.